Heart Valve Devices Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Published on : Apr-2020 | List of Tables : 80 | List of Figures : 47 | No. of Pages : 170 | Report Code : FACT4759MR | Format :

Global Heart Valve Devices Market Overview

The global heart valve devices market is poised to grow impressively, at a CAGR of 13.4% during the forecast period (2020-2025). Sedentary lifestyles, physical inactivity and other habits such as smoking have induced the prevalence of cardiovascular diseases. Consequently, the demand for minimally invasive procedures to address cardiac anomalies have increased substantially. Application of contemporary technologies in heart valve surgeries, such as the Transcatheter Aortic Valve Replacement (TAVR), have allowed room for increased preference for such surgeries. Key manufacturers are capitalizing on this trend to expand their sales.

The market is anticipated to surpass a valuation of US$ 16.2 Bn by the end of 2025. Increased life expectancy, resulting in a rising proportion of geriatric population, is also anticipated to boost market growth. This is attributed to the fact that larger lifespans are inversely proportional to good health. As the number of elderly people increase, incidences of cardiovascular problems also compound.

Global Heart Valve Devices Product Insights

Transcatheter heart valve devices exhibit a strong growth trajectory during the forecast period. Rising demand for minimally invasive procedures have prompted players to invest heavily in research and development of new surgical procedures. Moreover, product launches in transcatheter heart valve prosthesis such as SAPIEN Transcatheter Heart Valve, Magna Ease Aortic and Mitral Valves and PERIMOUNT Aortic/Mitral Valves, are anticipated to boost prospects of transcatheter valves. A market share of more than two-fifth is predicted for transcatheter heart valves segment.

Biological heart valves shall capture the second-largest market share, accounting for nearly one-third of the global heart valve devices market. Increased usage of biological heart valve grafts among patients below 60 years of age are boosting its demand. Prevention of formation of blood clots and non-requirement of anti-coagulant medicines are anticipated to bolster the growth of biological heart valves segment. Projected CAGR for biological heart valves is a whopping 13.0%.

heart valve devices market 01

To get detailed COVID-19 impact insights on the heart valve devices market, ask an analyst here

Global Heart Valve Devices Regional Insights

North America is projected to continue dominating the global heart valve devices market, registering more than two-fifths of the market share. Rising adoption of technologically advanced heart valve repair devices, in order to reduce treatment duration and procedures are poised to steer market growth. Also, increasing FDA approvals of transcatheter aortic valves is boosting revenue shares of key market players, thus augmenting the overall heart valve devices market. The North American heart valve devices market is projected to expand at a CAGR of 13.7% during the forecast period.

Following North America is Asia-Pacific, which shows promising expansion capabilities. Large investment by market players and improvement in healthcare infrastructure are key growth drivers. In volume terms, mechanical heart devices are projected to capture the maximum market, owing to increased life expectancy and affordable prices. The Asia-Pacific heart valve devices market is set to expand robustly at a CAGR of 14.4% during the forecast period.

heart valve devices market 02

To get a regional overview of the global heart valve devices market, request for a report sample here

Global Heart Valve Devices Manufacturing Companies

The global heart valve devices market is consolidated. The top three players constitute more than half of the overall heart valve devices market. Some prominent players are Edward Lifesciences Corporation, Medtronic, Abbott Laboratories, Boston Scientific Corporation, CryoLife Inc. and JenaValve Technology, Inc. All the market players focus primarily on technological developments to launch new devices.

Edward Lifesciences Corporation is the leading player in the heart valve devices market. It follows a three-pronged growth strategy: patient focused care, addressing unmet needs of structural heart disease patients and innovations. The company manufactures the SAPIEN Transcatheter Heart Valve, Magna Ease Aortic/Mitral Valve, PERIMOUNT Aortic/Mitral Valve and Theon Mitral/Aortic Valve.

Likewise, Abbott Laboratories product pipeline in the cardiovascular business segment consists of transcatheter aortic heart valve system, left arterial appendage occlude and pacemakers, among others. Its structural heart products segment include the MitraClip Transcatheter Mitral Valve Repair.

COVID-19 Impact Insights:

The ongoing COVID-19 pandemic is poised to affect the heart valve devices market to a significant extent. As healthcare professionals increasingly direct their resources towards caring for coronavirus infected patients, other health issues are being relegated to the back seat. While cardiac surgery units have a responsibility to the patient, they are equally responsible for the safety of their healthcare workers and the wider healthcare services in a region or country.

Therefore, healthcare organizations have urged practitioners to delay elective procedures. As nationwide lockdowns intensify, production cycles and supply chains are getting disrupted, causing shortage in essential equipment required for cardiac procedures.

Several key players, such as Edwards Lifesciences Corporation, have temporarily suspended production of heart valve devices in order to cater to COVID-19 patients. Likewise, Boston Scientific Corporation has redirected all its resources to fight the pandemic.  The company has boosted its production of ventilators and personal protective equipment such as masks and gloves to be provided to hospitals and other healthcare settings.

Analyst’s Viewpoint:

The global heart valve devices market is set to embark upon a positive growth trajectory, burgeoned by surging popularity of minimally invasive procedures. However, the COVID-19 pandemics shall inhibit the supply of heart valve devices, attributed to market players’ shifting focus towards addressing the pandemic.

Global Heart Valve Devices: Report Scope:

The recent report published by Fact.MR incorporates a detailed forecast on the global heart valve devices market prospects between 2020 and 2025. It includes an analysis of the key drivers, restraints and opportunities associated with the growth of the market. The report has been segmented on the basis of product type and end-users. Each segment also includes various sub-segments, which have been analyzed in terms of their revenue, market share and growth rate throughout the forecast period.

A regional landscape across five geographies (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) has been embedded. Each region is studied based on the segmentations mentioned above. A detailed competitive landscape, highlighting key players’ revenue and market shares, their key expansion strategies, product launches and SWOT analysis, has also been included within the scope of this report.

Global Heart Valve Devices Market- Scope of the Report

The recent study by Fact.MR on global heart valve devices market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that are currently determining the growth of global heart valve devices market. This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders as well as emerging players associated with the manufacturing of heart valve devices. The study also provides dynamics that are responsible for influencing the future status of the global heart valve devices market over the forecast period.

A detailed assessment of the global heart valve devices market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global heart valve devices market along with their product portfolio enhances the reliability of this comprehensive research study.

Global Heart Valve Devices Market: Report Summary

The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in global heart valve devices market across the globe.

A comprehensive estimate of the global heart valve devices market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of the global heart valve devices market during the forecast period. Price point comparison by region with global average price is also considered in the study.

Global Heart Valve Devices: Market Segmentation

Fact.MR has studied the global heart valve devices market with detailed segmentation on the basis of Type, End-user and key regions.

Type

End-user

Key Regions

  • Mechanical Heart Valves:
    • Aortic Valve
    • Mitral Valve
  • Hospitals
  • North America
  • Biological Heart Valve:
    • Aortic Valve
    • Mitral Valve
    • Pulmonary Valve
    • Tricuspid Valve
  • Ambulatory Surgical Centers
  • Europe
  • Transcatheter Valves:
    • Aortic Valve
    • Mitral Valve
    • Pulmonary Valve

 

  • Asia Pacific

 

 

  • Latin America

 

 

  • Middle East & Africa (MEA)

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

Global Heart Valve Devices Market: Analysis on Market Size Evaluation

The global heart valve devices market has been analyzed for each market segment, in terms of value (US$ Mn) and volume (units).

Market estimates at global and regional levels for heart valve devices is available in terms of “US$ Mn” for value and in terms of units for volume. A Y-o-Y growth contrast on prominent guidewire market segments, along with market attractiveness evaluation has been incorporated in the report.

Global Heart Valve Devices Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the global heart valve devices report, which have helped to deliver projection on the regional markets. These chapters include the regional macros (economic, and business environment outlook), which are expected to have a momentous influence on the growth of the global heart valve devices market during the forecast period.

Country-specific valuation on demand for heart valve devices has been offered for each regional market, along with the market scope, estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Global Heart Valve Devices Market: In-Depth Analysis on Competitive Landscape

The report sheds light on the leading manufacturers of global heart valve devices along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the provision of global heart valve devices, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which includes essentials such as product portfolio, key strategies along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the global heart valve devices market. Prominent manufacturers with established market presence in the global heart valve devices market are Edwards Lifesciences Corporation, Medtronic, Abbott Laboratories, Boston Scientific Corporation and JenaValve Technology, Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Heart Valve Devices Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Market Dynamics

        4.2.1. Drivers

            4.2.1.1. Longer life expectancy with growing aging population

            4.2.1.2. High prevalence of heart valve diseases

            4.2.1.3. Technological advancements

        4.2.2. Restraints

            4.2.2.1. Stringent government approval process

            4.2.2.2. High cost of minimally invasive procedures

        4.2.3. Opportunity

            4.2.3.1. Emerging markets with high unmet needs

            4.2.3.2. Effective treatment of Vulvular Heart disease

    4.3. Porter’s Five Force Analysis

    4.4. Market Outlook

    4.5. Pricing Analysis: Global Average Selling Price (US$), by Type, 2020 and 2025

5. Global Heart Valve Devices Market, Technological Trends

    5.1. Developed Technologies Trends

    5.2. Transcathether Mitral Market Trends

    5.3. Valve-in-valve Replacement Trends

    5.4. Latest Technological Trends

6. Global Heart Valve Devices Market, Mergers and Acquisitions, 2015-2019

7. Global Heart Valve Devices Market, Regulation for Approval of New Medical Devices

    7.1. PMA Regulations

    7.2. CE Mark Regulations

8. Global Heart Valve Devices Market Analysis and Forecasts, By Type 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Key Trends

    8.4. Market Value and Volume Forecast By Type, 2020–2025

        8.4.1. Mechanical Heart Valves

            8.4.1.1. Aortic Valves

            8.4.1.2. Mitral Valves

        8.4.2. Biological Heart Valves

            8.4.2.1. Aortic Valves

            8.4.2.2. Mitral Valves

            8.4.2.3. Pulmonary Valves

            8.4.2.4. Tricuspid Valves

        8.4.3. Transcatheter Heart Valves

            8.4.3.1. Aortic Valves

            8.4.3.2. Mitral Valves

            8.4.3.3. Pulmonary Valves

    8.5. Market Attractiveness By Type 

9. Global Heart Valve Devices Market Analysis and Forecasts, By End-user 

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Key Trends

    9.4. Market Value Forecast By End-user, 2020–2025

        9.4.1. Hospitals

        9.4.2. Ambulatory Surgical Centers

    9.5. Market Attractiveness By End-user 

10. Global Heart Valve Devices Market Analysis and Forecasts, By Region

    10.1. Key Findings

    10.2. Policies and Regulations

    10.3. Market Value Forecast By Region

        10.3.1. North America 

        10.3.2. Europe 

        10.3.3. Asia Pacific 

        10.3.4. Latin America 

        10.3.5. Middle East and Africa 

    10.4. Market Attractiveness By Country/Region

11. North America Heart Valve Devices Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value and Volume Forecast By Type, 2020–2025

        11.2.1. Mechanical Heart Valves

            11.2.1.1. Aortic Valves

            11.2.1.2. Mitral Valves

        11.2.2. Biological Heart Valves

            11.2.2.1. Aortic Valves

            11.2.2.2. Mitral Valves

            11.2.2.3. Pulmonary Valves

            11.2.2.4. Tricuspid Valves

        11.2.3. Transcatheter Heart Valves

            11.2.3.1. Aortic Valves

            11.2.3.2. Mitral Valves

            11.2.3.3. Pulmonary Valves

    11.3. Market Value Forecast By End-user, 2020–2025

        11.3.1. Hospitals

        11.3.2. Ambulatory Surgical Centers

    11.4. Market Value Forecast By Country, 2020–2025

        11.4.1. U.S.

        11.4.2. Canada

    11.5. Market Attractiveness Analysis 

        11.5.1. By Type 

        11.5.2. By End-user 

        11.5.3. By Country

12. Europe Heart Valve Devices Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value and Volume Forecast By Type, 2020–2025

        12.2.1. Mechanical Heart Valves

            12.2.1.1. Aortic Valves

            12.2.1.2. Mitral Valves

        12.2.2. Biological Heart Valves

            12.2.2.1. Aortic Valves

            12.2.2.2. Mitral Valves

            12.2.2.3. Pulmonary Valves

            12.2.2.4. Tricuspid Valves

        12.2.3. Transcatheter Heart Valves

            12.2.3.1. Aortic Valves

            12.2.3.2. Mitral Valves

            12.2.3.3. Pulmonary Valves

    12.3. Market Value Forecast By End-user, 2020–2025

        12.3.1. Hospitals

        12.3.2. Ambulatory Surgical Centers

    12.4. Market Value Forecast By Country, 2020–2025

        12.4.1. U.K.

        12.4.2. Germany

        12.4.3. France

        12.4.4. Italy

        12.4.5. Spain

        12.4.6. Russia

        12.4.7. Rest of Europe

    12.5. Market Attractiveness Analysis 

        12.5.1. By Type 

        12.5.2. By End-user 

        12.5.3. By Country

13. Asia Pacific Heart Valve Devices Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast By Type, 2020–2025

        13.2.1. Mechanical Heart Valves

            13.2.1.1. Aortic Valves

            13.2.1.2. Mitral Valves

        13.2.2. Biological Heart Valves

            13.2.2.1. Aortic Valves

            13.2.2.2. Mitral Valves

            13.2.2.3. Pulmonary Valves

            13.2.2.4. Tricuspid Valves

        13.2.3. Transcatheter Heart Valves

            13.2.3.1. Aortic Valves

            13.2.3.2. Mitral Valves

            13.2.3.3. Pulmonary Valves

    13.3. Market Value Forecast By End-user, 2020–2025

        13.3.1. Hospitals

        13.3.2. Ambulatory Surgical Centers

    13.4. Market Value Forecast By Country, 2020–2025

        13.4.1. India

        13.4.2. China

        13.4.3. Japan

        13.4.4. Australia & New Zealand

        13.4.5. Rest of Asia Pacific

    13.5. Market Attractiveness Analysis 

        13.5.1. By Type 

        13.5.2. By End-user 

        13.5.3. By Country

14. Latin America Heart Valve Devices Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value and Volume Forecast By Type, 2020–2025

        14.2.1. Mechanical Heart Valves

            14.2.1.1. Aortic Valves

            14.2.1.2. Mitral Valves

        14.2.2. Biological Heart Valves

            14.2.2.1. Aortic Valves

            14.2.2.2. Mitral Valves

            14.2.2.3. Pulmonary Valves

            14.2.2.4. Tricuspid Valves

        14.2.3. Transcatheter Heart Valves

            14.2.3.1. Aortic Valves

            14.2.3.2. Mitral Valves

            14.2.3.3. Pulmonary Valves

    14.3. Market Value Forecast By End-user, 2020–2025

        14.3.1. Hospitals

        14.3.2. Ambulatory Surgical Centers

    14.4. Market Value Forecast By Country, 2020–2025

        14.4.1. Brazil

        14.4.2. Mexico

        14.4.3. Rest of Latin America

    14.5. Market Attractiveness Analysis 

        14.5.1. By Type 

        14.5.2. By End-user 

        14.5.3. By Country

15. Middle East and Africa Heart Valve Devices Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value and Volume Forecast By Type, 2020–2025

        15.2.1. Mechanical Heart Valves

            15.2.1.1. Aortic Valves

            15.2.1.2. Mitral Valves

        15.2.2. Biological Heart Valves

            15.2.2.1. Aortic Valves

            15.2.2.2. Mitral Valves

            15.2.2.3. Pulmonary Valves

            15.2.2.4. Tricuspid Valves

        15.2.3. Transcatheter Heart Valves

            15.2.3.1. Aortic Valves

            15.2.3.2. Mitral Valves

            15.2.3.3. Pulmonary Valves

    15.3. Market Value Forecast By End-user, 2020–2025

        15.3.1. Hospitals

        15.3.2. Ambulatory Surgical Centers

    15.4. Market Value Forecast By Country, 2020–2025

        15.4.1. South Africa

        15.4.2. GCC Countries

        15.4.3. Rest of Middle East and Africa

    15.5. Market Attractiveness Analysis 

        15.5.1. By Type 

        15.5.2. By End-user 

        15.5.3. By Country

16. Competition Landscape

    16.1. Market Player – Competition Matrix (By Tier and Size of companies)

    16.2. Market Share Analysis By Company (2018)

    16.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

        16.3.1. Abbott Laboratories

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strengths)

            16.3.1.2. Financial Overview

            16.3.1.3. Product Portfolio

            16.3.1.4. SWOT Analysis

            16.3.1.5. Strategic Overview

        16.3.2. Boston Scientific Corporation 

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strengths)

            16.3.2.2. Financial Overview

            16.3.2.3. Product Portfolio

            16.3.2.4. SWOT Analysis

            16.3.2.5. Strategic Overview

        16.3.3. CryoLife, Inc. 

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strengths)

            16.3.3.2. Financial Overview

            16.3.3.3. Product Portfolio

            16.3.3.4. SWOT Analysis

            16.3.3.5. Strategic Overview

        16.3.4. Edward Lifesciences Corporation 

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strengths)

            16.3.4.2. Financial Overview

            16.3.4.3. Product Portfolio

            16.3.4.4. SWOT Analysis

            16.3.4.5. Strategic Overview

        16.3.5. JenaValve Technology, Inc. 

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strengths)

            16.3.5.2. Financial Overview

            16.3.5.3. Product Portfolio

            16.3.5.4. SWOT Analysis

            16.3.5.5. Strategic Overview

        16.3.6. Medtronic 

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strengths)

            16.3.6.2. Financial Overview

            16.3.6.3. Product Portfolio

            16.3.6.4. SWOT Analysis

            16.3.6.5. Strategic Overview

        16.3.7. SYMETIS 

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strengths)

            16.3.7.2. Financial Overview

            16.3.7.3. Product Portfolio

            16.3.7.4. SWOT Analysis

            16.3.7.5. Strategic Overview

        16.3.8. Neovasc, Inc. 

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strengths)

            16.3.8.2. Financial Overview

            16.3.8.3. Product Portfolio

            16.3.8.4. SWOT Analysis

            16.3.8.5. Strategic Overview 

        16.3.9. Sorin Group (LivaNova PLC) 

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strengths)

            16.3.9.2. Financial Overview

            16.3.9.3. Product Portfolio

            16.3.9.4. SWOT Analysis

            16.3.9.5. Strategic Overview

        16.3.10. Micro Interventional Devices, Inc.

            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strengths)

            16.3.10.2. Financial Overview

            16.3.10.3. Product Portfolio

            16.3.10.4. SWOT Analysis

            16.3.10.5. Strategic Overview

        16.3.11. XELTIS 

            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strengths)

            16.3.11.2. Financial Overview

            16.3.11.3. Product Portfolio

            16.3.11.4. SWOT Analysis

            16.3.11.5. Strategic Overview

        16.3.12. TTK HealthCare 

            16.3.12.1. Company Overview (HQ, Business Segments, Employee Strengths)

            16.3.12.2. Financial Overview

            16.3.12.3. Product Portfolio

            16.3.12.4. SWOT Analysis

            16.3.12.5. Strategic Overview

        16.3.13.Lepu Medical Technology (Beijing) Co., Ltd. (Lepu Medical Group)  

            16.3.13.1. Company Overview (HQ, Business Segments, Employee Strengths)

            16.3.13.2. Financial Overview

            16.3.13.3. Product Portfolio

            16.3.13.4. SWOT Analysis

            16.3.13.5. Strategic Overview

        16.3.14. Auto Tissue Berlin GmbH 

            16.3.14.1. Company Overview (HQ, Business Segments, Employee Strengths)

            16.3.14.2. Financial Overview

            16.3.14.3. Product Portfolio

            16.3.14.4. SWOT Analysis

            16.3.14.5. Strategic Overview

        16.3.15. Novostia SA

            16.3.15.1. Company Overview (HQ, Business Segments, Employee Strengths)

            16.3.15.2. Financial Overview

            16.3.15.3. Product Portfolio

            16.3.15.4. SWOT Analysis

            16.3.15.5. Strategic Overview

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Heart Valve Devices Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025